| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242443 | Respiratory Medicine | 2013 | 9 Pages |
Abstract
In uncontrolled or partly controlled asthma patients, the use of a combination of fluticasone propionate plus formoterol via DPI for 12-weeks was non-inferior and showed improvements in FEV1 and asthma control when compared to a combination of budesonide plus formoterol. (Clinical Trial number: ISRCTN60408425).
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
A. Cukier, C.M.A. Jacob, N.A. Rosario Filho, J. Fiterman, E.O. Vianna, J.L. Hetzel, M.A. Neis, E. Fiss, F.F.M. Castro, A.L.G. Fernandes, R. Stirbulov, E. Pizzichini, AIR Brazilian Study Group AIR Brazilian Study Group,